Table 5 Risk for plaque and total plaque area at follow-up in persons with no plaque present at baseline, according to categories of fish consumption: the Tromsø Study
From: Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study
Fish servings (times/wk) | N 1634 | Novel plaque N (%) | Risk for plaque OR (95% CI) | TPAa mm2 (SE) |
|---|---|---|---|---|
Total fish | ||||
< 1 | 116 | 44 (37.9) | 0.98 (0.62–1.54) | 1.52 (0.19) |
1–1.9 | 596 | 225 (37.8) | 1 (Reference) | 1.46 (0.08) |
2–2.9 | 416 | 181 (43.5) | 1.15 (0.87–1.52) | 1.62 (0.10) |
≥ 3 | 506 | 250 (49.4) | 1.32 (1.01–1.73) | 1.76 (0.09) |
p-trend | 0.04 | 0.02 | ||
Fatty fish | ||||
< 1 | 829 | 332 (40.1) | 0.90 (0.72–1.13) | 1.54 (0.07) |
1–1.9 | 631 | 280 (44.4) | 1 (Reference) | 1.63 (0.08) |
≥ 2 | 174 | 88 (50.6) | 1.18 (0.81–1.72) | 1.75 (0.16) |
p-trend | 0.1 | 0.2 | ||
Lean fish | ||||
< 1 | 142 | 55 (38.7) | 0.99 (0.65–1.49) | 1.57 (0.17) |
1–1.9 | 636 | 253 (39.8) | 1 (Reference) | 1.52 (0.08) |
≥ 2 | 856 | 392 (45.8) | 1.12 (0.89–1.41) | 1.66 (0.07) |
p –trend | 0.4 | 0.3 | ||